NKG2A&CD94 mFc Chimera, Flag, Mouse
NKG2A&CD94 MFc Chimera, Flag, Mouse

The purity of NKG2A&CD94 mFc Chimera, Flag, Mouse is greater than 95% as determined by SEC-HPLC.

NKG2A&CD94 MFc Chimera, Flag, Mouse

NKG2A&CD94 mFc Chimera, Flag, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

NKG2A&CD94 mFc Chimera, Flag, Mouse

The ligand-receptor assignment between HLA-G and NKG2A/CD94 is dependent of the amino acid composition in the HLA-G heavy chain. Understanding the biophysical basis of receptor-mediated events that lead to NK cell inhibition would help to remove non-tumor reactive cells and support personalized mild autologous NK cell therapies.
Z06280
¥72,752.00

Ask us a question
Product Introduction
Species Mouse
Protein Construction
Flag NKG2A&CD94 (Asn98-Ile244(NKG2A) and Ile32-Ile179(CD94))_x000D_
Accession # Q9WU31(NKG2A)&O54707(CD94)		 mFc (IgG1)
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 18.3 kDa (CD94) and 43.1 kDa (NKG2A)
Apparent Molecular Weight Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • NKG2A&CD94 MFc Chimera, Flag, Mouse
    • NKG2A&CD94 MFc Chimera, Flag, Mouse

    The purity of NKG2A&CD94 mFc Chimera, Flag, Mouse is greater than 95% as determined by SEC-HPLC.

  • NKG2A&CD94 MFc Chimera, Flag, Mouse
    • NKG2A&CD94 MFc Chimera, Flag, Mouse

    NKG2A&CD94 mFc Chimera, Flag, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The ligand-receptor assignment between HLA-G and NKG2A/CD94 is dependent of the amino acid composition in the HLA-G heavy chain. Understanding the biophysical basis of receptor-mediated events that lead to NK cell inhibition would help to remove non-tumor reactive cells and support personalized mild autologous NK cell therapies.
Synonyms CD159a; NKG2A; NKG2-A; CD94; NKG2A&CD94

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.